Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 36

1.

USP chapter 797: establishing a practice standard for compounding sterile preparations in pharmacy.

Kastango ES, Bradshaw BD.

Am J Health Syst Pharm. 2004 Sep 15;61(18):1928-38. No abstract available.

PMID:
15487884
2.

Compounding parenteral nutrition: reducing the risks.

Curtis C, Sacks GS.

Nutr Clin Pract. 2009 Aug-Sep;24(4):441-6. doi: 10.1177/0884533609339070. Review.

PMID:
19605798
3.
4.

Regulation of compounding by the food and drug administration: a tale of 2 circuits.

Williams KG.

J Pharm Pract. 2010 Oct;23(5):502-6. doi: 10.1177/0897190010366928. Epub 2010 May 20. Review.

PMID:
21507854
5.

Development of the antimicrobial effectiveness test as USP chapter <51>.

Sutton SV, Porter D.

PDA J Pharm Sci Technol. 2002 Nov-Dec;56(6):300-11. Review.

PMID:
12497767
6.

ASHP guidelines on compounding sterile preparations.

American Society of Health System Pharmacists.

Am J Health Syst Pharm. 2014 Jan 15;71(2):145-66. doi: 10.2146/sp140001. Review. No abstract available.

PMID:
24375608
7.

Pharmacy compounding of high-risk level products and patient safety.

Mullarkey T.

Am J Health Syst Pharm. 2009 Sep 1;66(17 Suppl 5):S4-13. doi: 10.2146/ajhp0108b. Review.

PMID:
19710449
8.

Basics of Sterile Compounding: Personnel Requirements for Sterile Compounding.

Akers MJ.

Int J Pharm Compd. 2016 Jul-Aug;20(4):307-314. Review.

PMID:
28333676
9.

Establishing powder-handling workflow practices and standard operating procedures: compounding pharmacy and safety.

Prince B, Lundevall J.

Int J Pharm Compd. 2014 May-Jun;18(3):222-6. Review.

PMID:
25306770
10.

Sterile compounding: clinical, legal, and regulatory implications for patient safety.

Qureshi N, Wesolowicz L, Stievater T, Lin AT.

J Manag Care Spec Pharm. 2014 Dec;20(12):1183-91. Review.

11.

Basics of compounding sterile preparations: nomenclature and considerations.

Allen LV Jr.

Int J Pharm Compd. 2014 Jul-Aug;18(4):313-7. Review.

PMID:
25474860
12.

New England Compounding Center Indictment.

Cabaleiro J.

Int J Pharm Compd. 2015 Mar-Apr;19(2):94-102. Review.

PMID:
26685489
13.

Sterile products: advances and challenges in formulation, manufacturing and regulatory aspects--a regulatory review perspective.

Hussong D.

AAPS PharmSciTech. 2010 Sep;11(3):1482-4. doi: 10.1208/s12249-010-9503-z. Epub 2010 Sep 16. Review.

14.

Activities of the USP Analytical Microbiology Expert Committee during the 2000-2005 revision cycle.

Sutton SV, Knapp JE, Porter D.

PDA J Pharm Sci Technol. 2005 May-Jun;59(3):157-76. Review.

PMID:
16048116
15.

[Compounding of ophthalmic drugs in the pharmacy. Special care must be taken!].

Daniels R.

Pharm Unserer Zeit. 2010 Jul;39(4):306-11. doi: 10.1002/pauz.201000377. Review. German. No abstract available.

PMID:
20589805
16.

Infusate contamination in regional anesthesia: what every anesthesiologist should know.

Head S, Enneking FK.

Anesth Analg. 2008 Oct;107(4):1412-8. doi: 10.1213/01.ane.0000286228.57455.91. Review.

PMID:
18806061
17.

Official USP Reference Standards: metrology concepts, overview, and scientific issues and opportunities.

Williams RL; 2000-2005 Reference Standards Committee of the USP Council of Experts and Its Advisory Panel; USP Staff and Consultant.

J Pharm Biomed Anal. 2006 Jan 23;40(1):3-15. Epub 2005 Nov 21. Review.

PMID:
16303277
18.

Injectable immunotherapy: recommendations for safe allergen vial preparation in the office setting.

Lay PC.

Curr Opin Otolaryngol Head Neck Surg. 2009 Jun;17(3):223-5. doi: 10.1097/MOO.0b013e32832b376f. Review.

PMID:
19395969
19.

Compounding pharmacies: who is in charge?

Pergolizzi JV Jr, Labhsetwar S, LeQuang JA.

Pain Pract. 2013 Mar;13(3):253-7. doi: 10.1111/papr.12033. Epub 2013 Jan 28. Review. Erratum in: Pain Pract. 2013 Apr;13(4):347.

PMID:
23350709
20.

Supplemental Content

Support Center